Case Study – Bulgaria


1. Amebiasis

2. Anthrax

3. Ascariasis

4. Bacterial meningitis and meningo-encephalitis:

4.1. With specified etiology

4.1.1. Pneumococcal

4.1.2. Streptococcal

4.1.3. Haemophilus influenzae

4.1.4. Other bacteria

4.2. With unspecified etiology

5. Botulism

6. Brucellosis

7. Rabies

8. Creutzfeldt-Jakob disease

9. Smallpox

10. Chickenpox

11. Viral meningitis and meningo-encephalitis

12. Viral haemorrhagic fevers:

12.1. Ebola and Marburg fever

12.2. Lassa fever

12.3. Congo-Crimean haemorrhagic fever

12.4. Haemorrhagic fever with renal syndrome

13. Viral hepatitis:

13.1. Acute viral hepatitis types A, B, C, D, unidentified

13.2. Chronic viral hepatitis type B, C, D

14. Gastroenteritis, enterocolitis

15. Gonococcal infection

16. Influenza and acute respiratory infections (ARI)

17. Shigellosis

18. Diphtheria

19. Mumps

20. Echinococcosis

21. Yellow fever

22. Yersiniosis

23. Campylobacteriosis

24. Pertussis

25. Enterohaemorrhagic E. coli infection

26. Typhoid fever

27. Cryptosporidiosis

28. Q fever

29. Lyme borreliosis

30. Leishmaniosis, visceral

31. Lambliosis

32. Legionellosis

33. Leptospirosis

34. Listeriosis

35. Malaria

36. Marseilles fever (Mediterranean spotted fever (MSF))

37. Meningococcal infection (meningo-coccal meningitis and sepsis)

38. Measles

39. Ornithosis

40. Spotted fever

41. Poliomyelitis

41.1. Acute Flaccid Paralysis

42. Rubella

42.1. Congenital rubella

43. Salmonellosis

44. Syndrome of acquired immune deficiency (AIDS) and HIV infection

45. Syphilis

46. Scarlet fever

47. Streptococcus pneumoniae, invasive infection

48. Severe acute respiratory syndrome (SARS)

49. Tapeworm infection (Taenia solium, Taenia saginata, Hymenolepis nana, and Diphyllobothrium latum)

50. Tetanus

51. Toxoplasmosis

52. Trichinosis

53. Tuberculosis

54. Tularaemia

55. Haemophilus influenzae type B invasive infection

56. Chlamydia trachomatis, genital infection

57. Cholera

58. Plague



The data for morbidity of the most important communicable diseases for the country is published in the weekly epidemiological bulletin (Table 8.2), published by the National Centre for Infectious and Parasitic Diseases.


Table 8.2
Epidemiological bulletin list






















































Anthrax

Lyme borreliosis

Bacterial meningitis and meningo-encephalitis

Legionellosis

Botulism

Leptospirosis

Brucellosis

Listeriosis

Chickenpox

Marseilles fever (Mediterranean spotted fever (MSF))

Crimean-Congo haemorrhagic fever

Meningococcal infection (meningo-coccal meningitis and sepsis)

Viral meningitis and meningo-encephalitis

Ornithosis

Gastroenteritis, enterocolitis

Acute viral hepatitis types A, B, C, D

Congenital rubella

Rubella

Shigellosis

Salmonellosis

Mumps

Scarlet fever

Pertussis

Tetanus

Yersiniosis

Tularaemia

Campylobacteriosis

Haemorrhagic fever with renal syndrome

E. coli enterocolitis

Chronic viral hepatitis type B, C, D

Typhoid fever
 

Contrary to the existing infectious diseases list, Bulgarian authorities do not have an established official list of potential agents for bioterrorism. In a recent publication we have proposed a list of bio-agents (Table 8.3) which represent a potential threat for Bulgarian citizens in case of bioterrorism, taking into account the following criteria [5]:


Table 8.3
Proposed list of bio-agents which represent a potential threat for Bulgarian citizens in case of bioterrorism










































Bacterial agents

Viral agents

Biological toxins

B. anthracis

SARS CoV

Botulinum toxin

Brucella spp.

H5N1

Ricin

B. mallei

H1N1

SEB

B. pseudomallei

Orthopox virus

T-2 mycotoxins

Y. pestis

Venezuelan equine encephalitis virus
 

F. tularensis

Haemorrhagic fever viruses

V. cholera
 

Rickettsia

C. burnetii
 




  • Bulgaria’s geographical position;


  • The immunization calendar of the country; and


  • The implementation of commitments to peacekeeping and other missions.

This lack of official position on the threat of biological agents needs to be further clarified. Until very recently according to the Bulgarian authorities there was no risk of terrorism in the country, including risk of bioterrorism. This attitude is changing and the new position of the government is that Bulgaria faces the risks and threats common to the Euro-Atlantic area which include terrorism and weapons of mass destruction.

The new National Security Strategy of the Republic of Bulgaria (NSS), adopted by the National Assembly on 25 February 2011, states that “risks and threats (including bioterrorism) to the security of the Republic of Bulgaria and its citizens largely coincide or are similar to those that threaten other EU countries and NATO” [4].

The strategy gives special attention to asymmetric threats, especially international terrorism and proliferation of weapons of mass destruction (WMD) and their impact on security in a global and regional context. The document underlines the increasing possibilities of the use of radioactive materials, toxic substances and biological agents, as well as access to information databases and technology for the combat of terrorism.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 21, 2016 | Posted by in BIOCHEMISTRY | Comments Off on Case Study – Bulgaria

Full access? Get Clinical Tree

Get Clinical Tree app for offline access